ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

TLSI TriSalus Life Sciences Inc

9,85
0,15 (1,55%)
18 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
TriSalus Life Sciences Inc TLSI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,15 1,55% 9,85 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,56 9,52 9,89 9,85 9,70
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.5.202414:00BWTriSalus Reports Q1 2024 Financial Results and Business..
07.5.202413:00BWTriSalus Life Sciences Appoints Liselotte Hyveled to its..
06.5.202422:58BWTriSalus Life Sciences to Host First Quarter 2024 Financial..
30.4.202422:35BWTriSalus Life Sciences Secures up to $50 million of Debt..
01.4.202414:00BWTriSalus Reports Q4 and Full Year 2023 Financial Results and..
26.3.202413:00BWTriSalus Life Sciences Technology Featured in Two..
21.3.202413:00BWTriSalus Life Sciences Announces Oral Presentations at the..
11.3.202422:15BWTriSalus Life Sciences Announces Q4 Conference Call and..
07.3.202413:00BWTriSalus Life Sciences Receives Approval from the World..
29.2.202413:00BWTriSalus Life Sciences Announces Real-World Data..
15.2.202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25.1.202423:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25.1.202423:19EDGAR2Form 8-K - Current report
05.1.202422:28EDGAR2Form 8-K - Current report
27.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
26.12.202323:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26.12.202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.11.202314:00BWTriSalus Reports Third Quarter 2023 Financial Results and..
07.11.202322:05BWTriSalus Life Sciences to Host Third Quarter 2023 Financial..
04.11.202319:25BWLate-Breaking Phase 1 Liver Metastasis Data from TriSalus..
03.11.202317:00BWTriSalus Life Sciences Presents Data for SD-101 Delivered by..
25.10.202315:05BWTriSalus Life Sciences Announces Late Breaker and Additional..
19.10.202303:58EDGAR2Form S-1/A - General form for registration of securities..
16.10.202323:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
03.10.202312:01EDGAR2Form 8-K - Current report
06.9.202313:00BWTriSalus Life Sciences Appoints Jodi Devlin as President of..
01.9.202322:47EDGAR2Form S-1/A - General form for registration of securities..
01.9.202322:01EDGAR2Form 8-K - Current report
01.9.202303:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.9.202303:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
31.8.202323:22EDGAR2Form S-1 - General form for registration of securities under..
29.8.202314:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21.8.202322:33EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16.8.202322:37EDGAR2Form 8-K - Current report